scholarly article | Q13442814 |
P50 | author | Jinxin Che | Q90951619 |
P2093 | author name string | Feng Huang | |
Zhilong Wang | |||
Xin Xie | |||
Yongzhou Hu | |||
Xiaowu Dong | |||
Youhong Hu | |||
Haichao Sheng | |||
P2860 | cites work | CXCR2: a target for pancreatic cancer treatment? | Q27021588 |
Integrins in cancer: biological implications and therapeutic opportunities | Q29614536 | ||
Cancer metastasis: building a framework | Q29616783 | ||
Induction of CXCR2 ligands, stem cell-like phenotype, and metastasis in chemotherapy-resistant breast cancer cells. | Q30353532 | ||
Drug design strategies for targeting G-protein-coupled receptors | Q30859422 | ||
The interleukin-8 pathway in cancer. | Q34871322 | ||
CXCR2 receptor antagonists: a medicinal chemistry perspective | Q35232382 | ||
Discovery of Novel CXCR2 Inhibitors Using Ligand-Based Pharmacophore Models | Q35685711 | ||
CXCR2 Inhibition Profoundly Suppresses Metastases and Augments Immunotherapy in Pancreatic Ductal Adenocarcinoma | Q36041701 | ||
Discovery of Novel Succinate Dehydrogenase Inhibitors by the Integration of in Silico Library Design and Pharmacophore Mapping. | Q36327898 | ||
Recent advances in MMP inhibitor design | Q36471137 | ||
The role of CXC chemokines and their receptors in cancer. | Q37200003 | ||
Why does cancer therapy lack effective anti-metastasis drugs? | Q38051530 | ||
Recent advances in structure-based drug design and virtual screening of VEGFR tyrosine kinase inhibitors. | Q38252759 | ||
Discovery of flavonoid derivatives as anti-HCV agents via pharmacophore search combining molecular docking strategy | Q39374670 | ||
Potential of Integrin Inhibitors for Treating Ovarian Cancer: A Literature Review | Q39429469 | ||
Targeting FGFR/PDGFR/VEGFR impairs tumor growth, angiogenesis, and metastasis by effects on tumor cells, endothelial cells, and pericytes in pancreatic cancer. | Q39480718 | ||
Inhibition of multiple vascular endothelial growth factor receptors (VEGFR) blocks lymph node metastases but inhibition of VEGFR-2 is sufficient to sensitize tumor cells to platinum-based chemotherapeutics | Q40006197 | ||
Synthesis and structure-activity relationships of 3,4-diaminocyclobut-3-ene-1,2-dione CXCR2 antagonists | Q40280551 | ||
Interleukin-8 and its receptor CXCR2 in the tumour microenvironment promote colon cancer growth, progression and metastasis. | Q42181728 | ||
Three dimensional pharmacophore modeling of human CYP17 inhibitors. Potential agents for prostate cancer therapy. | Q44747127 | ||
3,4-Diamino-2,5-thiadiazole-1-oxides as potent CXCR2/CXCR1 antagonists | Q46898022 | ||
Discovery of oxazole and triazole derivatives as potent and selective S1P(1) agonists through pharmacophore-guided design. | Q51747458 | ||
Constructing and Validating 3D-pharmacophore Models to a Set of MMP-9 Inhibitors for Designing Novel Anti-melanoma Agents. | Q52856612 | ||
2-Aminopyrimidin-4(1H)-one as the novel bioisostere of urea: discovery of novel and potent CXCR2 antagonists. | Q53247930 | ||
Pharmacophore identification, docking and "in silico" screening for novel CDK1 inhibitors. | Q54509182 | ||
N,N'-Diarylcyanoguanidines as antagonists of the CXCR2 and CXCR1 chemokine receptors | Q80171436 | ||
C(4)-alkyl substituted furanyl cyclobutenediones as potent, orally bioavailable CXCR2 and CXCR1 receptor antagonists | Q80218015 | ||
3-Arylamino-2H-1,2,4-benzothiadiazin-5-ol 1,1-dioxides as novel and selective CXCR2 antagonists | Q80380661 | ||
Pharmacophore-Map-Pick: A Method to Generate Pharmacophore Models for All Human GPCRs | Q88061067 | ||
P433 | issue | 7 | |
P304 | page(s) | 180176 | |
P577 | publication date | 2018-07-04 | |
P1433 | published in | Royal Society Open Science | Q18712516 |
P1476 | title | Ligand-based pharmacophore model for the discovery of novel CXCR2 antagonists as anti-cancer metastatic agents | |
P478 | volume | 5 |
Q99630072 | Development of simultaneous interaction prediction approach (SiPA) for the expansion of interaction network of traditional Chinese medicine |
Q92651431 | Digital gene expression analyses of mammary glands from meat ewes naturally infected with clinical mastitis |
Q91713632 | Pharmacophore-Based Virtual Screening Toward the Discovery of Novel Anti-echinococcal Compounds |
Q90430431 | Pharmmaker: Pharmacophore modeling and hit identification based on druggability simulations |
Q58606442 | The role of CXCR2 in acute inflammatory responses and its antagonists as anti-inflammatory therapeutics |
Search more.